Profil
Claude Vezeau is President, Chief Executive Officer and Founder of Innodia, Inc. Prior to that, he was President of BioChem Vaccines, a division of BioChem Pharma, Inc. He has 20 years of pharmaceutical experience which includes clinical research, product development, sales and marketing, business development and operations.
Dr. Vezeau received a Doctorate degree in Pharmacy from the University of Minnesota.
Postes actifs de Claude Vezeau
| Sociétés | Poste | Début |
|---|---|---|
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Directeur Général | 01/01/2002 |
Anciens postes connus de Claude Vezeau
| Sociétés | Poste | Fin |
|---|---|---|
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | President | - |
Formation de Claude Vezeau
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Biochem Pharma, Inc.
Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
















